Ticker: IONS

Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) has reported its quarterly results for the period ending June 30, 2025. The company has experienced notable financial shifts, partly due to its recent commercialization efforts. Key Highlights: Total Revenue: $452.0 million for Q2 2025, up from $225.3 m...